ADVANCED FACILITY
Traditional growing in a GMP capable state of the art cultivation and processing facility supported by Canada's premier cultivation experts
Experion Holdings Reports Financial Results for Q4 and FYE Nov 30, 2020
March 29th, 2021
GROWING YOUR INVESTMENT THROUGH CANNABIS.
Experion is a Federally Licensed Cannabis company focused on distributing high quality cannabis products. With its state of the art facility, ability to source, process and distribute products nationally, is there opportunity? Plenty.
The underlying reason why investors originally invested in this sector remains the same: cannabis is and will continue to be a thriving multi-billion-dollar industry, with significant growth potential year over year.
There has never been a better time:
-
Cannabis consumers are projected to spend U.S. $5.2 billion in Canada by 2024
-
The medical marijuana market in Canada has the potential to be U.S. $1.88 billion by 2025
-
Global cannabis spending is expected to reach U.S. $66.3 billion by the end of 2025
Current markets
(TSXV:EXP) (OTCQB:EXPFF)
-
$0.3100
CURRENT ($)
-
-0.01
24-hour Change ($)
-
-1.59%
24-hour Change (%)
Experion advantages
Driving shareholder value through the distribution of quality cannabis products.
-
-
RESEARCH
Developing a bank of over 60 genetic strains and administering Canada's first Stage 3 clinical trial for pain management with cannabis
-
PARTNERSHIPS
Driving shareholder value through productive partnerships with only the best cannabis producers, discerning retailers and innovative manufacturers
-
GLOBAL EXPORT
Expertise, skill set and network to take advantage of global export opportunities
Press releases
-
-
Experion Announces Fiscal Year End Q4 2020 Financial Reporting Release Date and Earnings Call
March 18th, 2021
-
Experion and The Valens Company Enter into Pre-Roll Manufacturing Agreement
March 11th, 2021
-
Citizen Stash Expands its Product Line by 44% in Ontario, Canada’s Largest Cannabis Market
March 2nd, 2021
-
Citizen Stash Cannabis Edibles Enters Largest Canadian Market
February 24th, 2021
-
Experion Closes $2.5 million Loan Agreement
February 9th, 2021
Public filings
The numbers
-
$5.2B
Projected spend Adult-use cannabis in Canada by 2024 (USD)
-
$1.88B
Potential size of the Medical marijuana market in Canada by 2025 (USD)
-
$2.03B
Expected Canadian market size for alternative cannabis products annually starting 2020 (USD)
-
$66.3B
Global cannabis spend by the end of 2025 (USD)
THE KEY POINT
As the world continues to shift towards the legalization of cannabis, Experion has a unique advantage to distribute high quality flower and therapeutic products on a global platform
LET’S CONFIRM YOU’RE AT LEGAL AGE TO ENTER OUR SITE.
You must be of legal age in accordance with the law of your province to access this website and/or to purchase cannabis. By entering this site you agree to our terms and conditions and privacy policy.